The FDA has approved the use of tucatinib — a drug engineered by biotech company Seagen — in tandem with trastuzumab as a second-line treatment for colorectal cancer that has not responded to other therapies.
Category: ROOT
Washington physician facing lawsuit over patient misconduct
James Grierson, MD, of Marysville, Wash., has been sued by a former patient for sexual misconduct, HeraldNet reported Jan. 20.
Former J&J exec joins CXL Ophthalmics as board chair
Ophthalmic surgeon Jonathan Talamo, MD, has been appointed chair of the board of directors for CXL Ophthalmics.
Michigan Medicine appoints interim ophthalmology chair
Shahzad Mian, MD, has been appointed interim chair of the department of ophthalmology and visual sciences at the Michigan Medicine medical school in Ann Arbor, effective Jan. 15.
Online rating platforms direct patients to higher-quality physicians: Study
Nearly 75 percent of patients turn to online reviews as the first step when searching for a new physician. Despite their popularity, it’s largely been unclear whether online ratings are reliable or signal quality information to patients. A new study su…
8 RCM companies making executive moves
Eight revenue cycle management companies — including Conifer Health Solutions and R1 RCM — have announced executive leadership changes since Nov. 8:
Ohio Sears converted into medical office building
A former Sears department store in Ontario, Ohio, will open as a medical office building by the end of January, according to a Jan. 20 report from Mansfield News Journal.
Viewpoint: Antitrust strategies could rein in healthcare costs
When there’s less competition, prices are higher. That’s one fundamental principle of economics that applies to all markets, and this is especially true in healthcare, where American hospitals are the driver of the rising cost of care, Barak Richm…
5 gastroenterologists to know
Here are five physicians to know who specialize in gastroenterology:
Pharmacist-led protocols could improve patient sedation outcomes
Researchers found patients have worse outcomes when put under early deep sedation in the intensive care unit, but pharmacist-led protocols could help.
